Log In
BCIQ
Print this Print this
 

OBI-858

  Manage Alerts
Collapse Summary General Information
Company OBI Pharma Inc.
DescriptionBotulinum toxin
Molecular Target
Mechanism of ActionInhibits neurotransmitter release
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPreclinical
Standard IndicationSpasticity
Indication DetailsTreat muscle spasticity
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today